StockNews.AI

electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million

StockNews.AI • 2 days

ACADNVROABBV
High Materiality8/10

Information

ROCKAWAY, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or...

Original source

AI Summary

electroCore expects record revenue of $31.8-$32.0 million in FY 2025, reflecting a 26% growth from 2024. Anticipated Q4 results point to robust performance with 30% growth. These figures may enhance investor confidence, positioning ECOR positively moving forward.

Sentiment Rationale

Historically, announcements of strong revenue growth lead to stock price appreciation. Given current growth rates, investor confidence is likely to rise.

Trading Thesis

Hold ECOR for potential upward movement in anticipation of strong earnings results.

Market-Moving

  • Record revenue estimates could push ECOR's stock price higher.
  • Sustained cash position may attract new investors.
  • 30% projected growth in Q4 indicates strong market demand.

Key Facts

  • electroCore anticipates FY 2025 revenue of $31.8-$32.0 million.
  • Projected revenue growth is around 26% over FY 2024.
  • Q4 2025 revenue is expected to be $9.0-$9.2 million, up 30%.
  • Total cash as of Dec 31, 2025, is approximately $11.6 million.
  • Earnings call scheduled for March 2026 to provide detailed updates.

Companies Mentioned

  • electroCore, Inc. (ECOR): Projected revenue growth could signify structural improvement.

Corporate Developments

This falls under 'Corporate Developments' as it signals positive financial outcomes for electroCore, reflecting operational success and growth potential.

electroCore Reports Strong Preliminary Financial Guidance for 2025

ROCKAWAY, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a leading bioelectronic technology company, has announced its preliminary financial results for the full year 2025, showcasing record revenue and substantial growth. The company anticipates generating approximately $31.8 - $32.0 million in revenue for the year, reflecting a remarkable 26% increase compared to 2024, and approximately $9.0 - $9.2 million for the fourth quarter alone.

Preliminary Financial Insights

In its latest release, electroCore provided key financial guidance which outlines the following:

  • Full-Year Revenue: Expected to be in the range of $31.8 - $32.0 million, indicating a growth of 26% over 2024's revenue of $25.2 million.
  • Fourth Quarter Revenue: Projected at approximately $9.0 - $9.2 million, marking an impressive growth of 30% over the same quarter in 2024.
  • Total Cash Position: The company's cash, cash equivalents, and marketable securities totaled about $11.6 million as of December 31, 2025, down from $13.2 million on September 30, 2025.

Future Outlook and Financial Call

electroCore has expressed its intention to hold a detailed operational and financial update during its forthcoming fourth quarter and full-year 2025 earnings call scheduled for March 2026. This call will provide further clarity on the company's business trajectories and developments.

About electroCore, Inc.

electroCore, Inc. is dedicated to enhancing health and quality of life through pioneering non-invasive bioelectronic technologies. Among its flagship products are:

  • gammaCore®: A non-invasive vagus nerve stimulation device designed to treat various chronic pain syndromes.
  • Quell®: A neurostimulator that targets chronic pain.
  • Truvaga™ and TAC-STIM™: Personal-use bioelectronic devices aimed at promoting general wellness and improving human performance.

Important Forward-Looking Statements

This press release includes forward-looking statements under the Private Securities Litigation Reform Act of 1995, covering revenue expectations for 2025 and the company’s future business prospects. These statements, including anticipated growth and financial conditions, are subject to various risks and uncertainties that could lead to actual results differing materially. Key factors may include:

  • Market competition and the commercial viability of electroCore's products.
  • Economic conditions, including inflation and currency fluctuations.
  • The company's ability to secure additional funding for ongoing operations and product development.

Investors are encouraged to review all information provided and to consult the risk factor disclosures in electroCore’s reports filed with the SEC at www.sec.gov.

Contact Information

For additional inquiries, please reach out to:

ECOR Investor Relations
Phone: (973) 302-9253
Email: investors@electrocore.com

Related News